Amnon Lahad

3.5k total citations
61 papers, 2.4k citations indexed

About

Amnon Lahad is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Genetics. According to data from OpenAlex, Amnon Lahad has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 13 papers in Pharmacology and 13 papers in Genetics. Recurrent topics in Amnon Lahad's work include Musculoskeletal pain and rehabilitation (12 papers), BRCA gene mutations in cancer (10 papers) and Lysosomal Storage Disorders Research (7 papers). Amnon Lahad is often cited by papers focused on Musculoskeletal pain and rehabilitation (12 papers), BRCA gene mutations in cancer (10 papers) and Lysosomal Storage Disorders Research (7 papers). Amnon Lahad collaborates with scholars based in Israel, United States and United Kingdom. Amnon Lahad's co-authors include Ephrat Levy‐Lahad, Mary‐Claire King, Paul Renbaum, Michael Kaplan, Cathy Hammerman, Ernest Beutler, Hege R. Eriksen, Gernot Müller, Kim Burton and Annette Leclerc and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Amnon Lahad

57 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amnon Lahad Israel 25 743 622 591 438 374 61 2.4k
Karl‐Fredrik Eriksson Sweden 27 661 0.9× 224 0.4× 1.3k 2.2× 1.3k 2.9× 276 0.7× 56 4.3k
Melinda M. Protani Australia 17 128 0.2× 534 0.9× 446 0.8× 345 0.8× 96 0.3× 31 2.2k
Heather Spencer Feigelson United States 23 613 0.8× 111 0.2× 657 1.1× 615 1.4× 115 0.3× 33 3.1k
Sherri‐Ann M. Burnett‐Bowie United States 32 572 0.8× 175 0.3× 1.3k 2.2× 286 0.7× 120 0.3× 78 4.3k
Karol M. Pencina United States 27 118 0.2× 301 0.5× 390 0.7× 356 0.8× 76 0.2× 87 3.2k
Tomi S. Mikkola Finland 29 1.2k 1.6× 68 0.1× 244 0.4× 341 0.8× 85 0.2× 147 3.1k
Osamu Arisaka Japan 23 461 0.6× 78 0.1× 546 0.9× 211 0.5× 436 1.2× 186 2.3k
Lauren Nathan United States 18 742 1.0× 87 0.1× 246 0.4× 285 0.7× 142 0.4× 26 2.2k
Laura Bazzichi Italy 29 57 0.1× 335 0.5× 338 0.6× 431 1.0× 91 0.2× 74 1.9k
Pierre‐Antoine Dugué Australia 28 186 0.3× 421 0.7× 708 1.2× 548 1.3× 336 0.9× 96 2.6k

Countries citing papers authored by Amnon Lahad

Since Specialization
Citations

This map shows the geographic impact of Amnon Lahad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amnon Lahad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amnon Lahad more than expected).

Fields of papers citing papers by Amnon Lahad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amnon Lahad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amnon Lahad. The network helps show where Amnon Lahad may publish in the future.

Co-authorship network of co-authors of Amnon Lahad

This figure shows the co-authorship network connecting the top 25 collaborators of Amnon Lahad. A scholar is included among the top collaborators of Amnon Lahad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amnon Lahad. Amnon Lahad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lieberman, Sari, Ming K. Lee, Süleyman Gülsüner, et al.. (2024). TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. JNCI Journal of the National Cancer Institute. 117(5). 1069–1073.
2.
Levine, Alex J., Tamar Landau, Amnon Lahad, et al.. (2024). Artificial intelligence-enabled non-invasive ubiquitous anemia screening: The HEMO-AI pilot study on pediatric population. Digital Health. 10. 599940769–599940769.
3.
Michaelson‐Cohen, Rachel, Matan J. Cohen, Dan Greenberg, et al.. (2022). Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers. 14(24). 6113–6113. 4 indexed citations
4.
Søgaard, Jes, et al.. (2022). Similarities and differences between two well-performing healthcare systems: a comparison between the Israeli and the Danish healthcare systems. Israel Journal of Health Policy Research. 11(1). 14–14. 8 indexed citations
5.
Paltiel, Ora, Hagit Hochner, David Chinitz, et al.. (2021). Academic activism on behalf of children during the COVID-19 pandemic in Israel; beyond public health advocacy. Israel Journal of Health Policy Research. 10(1). 48–48. 9 indexed citations
6.
Lieberman, Sari, et al.. (2016). Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience. Genetics in Medicine. 19(6). 628–634. 25 indexed citations
7.
Lieberman, Sari, Oded Olsha, Shalom Strano, et al.. (2016). Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral. Genetics in Medicine. 19(7). 754–762. 40 indexed citations
8.
Gazy, Inbal, David A. Zeevi, Paul Renbaum, et al.. (2015). TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair. PLoS ONE. 10(7). e0134120–e0134120. 33 indexed citations
9.
Shani, Michal, Sasson Nakar, Alex Lustman, Amnon Lahad, & Shlomo Vinker. (2014). Structured nursing follow-up: does it help in diabetes care?. Israel Journal of Health Policy Research. 3(1). 27–27. 7 indexed citations
10.
Finestone, Aharon S., Simon Vulfsons, Charles Milgrom, et al.. (2013). The case for orthopaedic medicine in Israel. Israel Journal of Health Policy Research. 2(1). 42–42. 3 indexed citations
11.
Karkabi, Khaled, et al.. (2010). A shift to ambulatory medical education in Israel. The Clinical Teacher. 7(2). 126–130. 4 indexed citations
12.
Shani, Michal, Thomas R. Taylor, Shlomo Vinker, et al.. (2008). Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control. The Journal of the American Board of Family Medicine. 21(6). 490–496. 39 indexed citations
13.
Lahad, Amnon, et al.. (2008). Attitudes of couples identified through screening as carriers of Gaucher disease type 1. Clinical Genetics. 74(6). 566–570. 9 indexed citations
14.
Lahad, Amnon, et al.. (2007). Association between maternal and adult offspring utilization of primary healthcare.. PubMed. 9(2). 86–9. 4 indexed citations
15.
Lahad, Amnon, Amir Shmueli, Ari Zimran, et al.. (2007). Carrier Screening for Gaucher Disease. JAMA. 298(11). 1281–1281. 59 indexed citations
17.
Lahad, Amnon, et al.. (2001). Health behavior in a kibbutz population: correlations among different modalities of healthcare utilization.. PubMed. 3(12). 898–902. 9 indexed citations
18.
Gielchinsky, Yuval, Deborah Elstein, Irith Hadas‐Halpern, et al.. (1999). Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease. British Journal of Haematology. 106(3). 812–816. 33 indexed citations
19.
Azuri, Joseph, Deborah Elstein, Amnon Lahad, et al.. (1998). Asymptomatic Gaucher Disease Implications for Large-Scale Screening. Genetic Testing. 2(4). 297–299. 41 indexed citations
20.
Elstein, Deborah, Irith Hadas‐Halpern, Menachem Itzchaki, Amnon Lahad, & Ayala Abrahamov. (1996). Effect of Low-dose Enzyme Replacement Therapy on Bones in Gaucher Disease Patients with Severe Skeletal Involvement. Blood Cells Molecules and Diseases. 22(2). 104–111. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026